Recent

% | $
Quotes you view appear here for quick access.

Opko Health, Inc. Message Board

  • lilpimpinmf lilpimpinmf Sep 25, 2013 11:27 PM Flag

    Hey everybody look what Aristides Capital said when I asked

    how their OPK short at $4 range last October was coming along these days..........

    Lilpimpinmf

    September 22 at 11:23pm

    How is your OPK short position coming along since last October when it
    was in the $4 range?

    Aristides Capital

    September 23 at 3:10pm

    it's larger now.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Li

      I read again. Glad I do not have money with Aristides Capital. Their article was shady when they wrote about insider selling. Glad I am not short. How many shorts actually positive?

      Thanks
      Drangles

    • 4k Score™ should generate on the low side around $384,000,000 in revenue annually if it captures 5% of the US PSA test market and charges $256. More realistically however if the company can manage to capture just 15% of the US market then it should generate north of $1B annually. If we take into account global market populations than attaining $1B annually for Opko appears to be even more likely. In looking at this figure from a shareholder's perspective, if in the future OPK can manage to net in this $1B range with a P/E of at least 30 and 415,000,000 shares outstanding, this would equal a share price of $72.28. Yet if we take in to consideration other near term product revenues, or assign a P/E or P/S ratio the likes of the similar diagnostic companies highlighted above, investors could realistically see Opko Health go on to graduate from double digits to the next tier.

 
OPK
9.97+0.020(+0.20%)Jul 26 4:00 PMEDT